LoginRegister
    Shanghai Junshi Biosciences soars 21 percent on Hong Kong debutShanghai Junshi Biosciences soars 21 percent on Hong Kong debut
    Indias richest saw Rs 2100 crore vanish in 2018, Shanghvi lost Rs 460 crore: BloombergIndia's richest saw Rs 2100 crore vanish in 2018, Shanghvi lost Rs 460 crore: Bloomberg
    Lupin and AbbVie announces partnership to develop, commercialize Novel Oncology DrugLupin and AbbVie announces partnership to develop, commercialize Novel Oncology Drug
    Zydus Cadila gets USFDA nod for Doxycycline Hyclate delayed-release tablets,Febuxostat tabletsZydus Cadila gets USFDA nod for Doxycycline Hyclate delayed-release tablets,Febuxostat tablets
    Novartis to buy FranceNovartis to buy France's CellforCure to boost cell, gene therapy
    CDSCO increases licence fee for various application proceduresCDSCO increases licence fee for various application procedures
    Aurobindo Pharma gets USFDA nod for Potassium Chloride extended-release tabletsAurobindo Pharma gets USFDA nod for Potassium Chloride extended-release tablets
    Torrent Pharma issues voluntary nationwide recall of Losartan Potassium tablets: USFDATorrent Pharma issues voluntary nationwide recall of Losartan Potassium tablets: USFDA
    USFDA panel backs prescribing NALOXONE along with painkillersUSFDA panel backs prescribing NALOXONE along with painkillers
    Pharma industry returns on R&D investment hit 9-year lowPharma industry returns on R&D investment hit 9-year low
    Another trouble for J&J: CDSCO seize samples of baby products for testingAnother trouble for J&J: CDSCO seize samples of baby products for testing
    Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBIFortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBI
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X